Keywords: بازدارنده تیروزیین کیناز EGFR; EGFR tyrosine kinase inhibitor; Gefitinib; Osimertinib; Afatinib;
مقالات ISI بازدارنده تیروزیین کیناز EGFR (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: بازدارنده تیروزیین کیناز EGFR; Acquired resistance; Drug sensitivity; EGFR tyrosine kinase inhibitor; Non–small-cell lung cancer; Organ
EGFR-TKIs plus chemotherapy demonstrated superior efficacy than EGFR-TKIs alone as first-line setting in advanced NSCLC patients with EGFR mutation and BIM deletion polymorphism
Keywords: بازدارنده تیروزیین کیناز EGFR; BIM deletion polymorphism; Non-small-cell lung cancer; Epidermal growth factor receptor mutation; EGFR tyrosine kinase inhibitor; Chemotherapy;
Clinical Implications of the T790M Mutation in Disease Characteristics and Treatment Response in Patients With Epidermal Growth Factor Receptor (EGFR)-Mutated Non-Small-Cell Lung Cancer (NSCLC)
Keywords: بازدارنده تیروزیین کیناز EGFR; Acquired resistance; Chemotherapy; EGFR tyrosine kinase inhibitor; Progression-free survival; Targeted therapy;
Overexpression of YAP1 in EGFR mutant lung adenocarcinoma prior to tyrosine kinase inhibitor therapy is associated with poor survival
Keywords: بازدارنده تیروزیین کیناز EGFR; Lung adenocarcinoma; YAP1; EGFR tyrosine kinase inhibitor; Prognosis;
Three new disease-progression modes in NSCLC patients after EGFR-TKI treatment by next-generation sequencing analysis
Keywords: بازدارنده تیروزیین کیناز EGFR; Non-small-cell lung cancer; EGFR tyrosine kinase inhibitor; Disease progression; Sequencing;
Pneumonitis in advanced non-small-cell lung cancer patients treated with EGFR tyrosine kinase inhibitor: Meta-analysis of 153 cohorts with 15,713 patients
Keywords: بازدارنده تیروزیین کیناز EGFR; EGFR tyrosine kinase inhibitor; Pneumonitis; Non-small-cell lung cancer; Meta-analysis;
Clinical Likelihood of Sporadic Primary EGFR T790M Mutation in EGFR-Mutant Lung Cancer
Keywords: بازدارنده تیروزیین کیناز EGFR; Drug resistance; Drug sensitivity; EGFR tyrosine kinase inhibitor; EGFR mutation; Non–small-cell lung cancer; Sequencing
Impact of single nucleotide polymorphisms on severe hepatotoxicity induced by EGFR tyrosine kinase inhibitors in patients with non-small cell lung cancer harboring EGFR mutations
Keywords: بازدارنده تیروزیین کیناز EGFR; Lung cancer; EGFR tyrosine kinase inhibitor; Hepatotoxicity; Single nucleotide polymorphism;
Multiple resistant factors in lung cancer with primary resistance to EGFR-TK inhibitors confer poor survival
Keywords: بازدارنده تیروزیین کیناز EGFR; Non-small cell lung carcinoma; Epidermal growth factor receptor mutation; EGFR tyrosine kinase inhibitor; Primary resistance; Overall survival; BIM polymorphism;
A Neoadjuvant, Randomized, Open-Label Phase II Trial of Afatinib Versus Trastuzumab Versus Lapatinib in Patients With Locally Advanced HER2-Positive Breast Cancer
Keywords: بازدارنده تیروزیین کیناز EGFR; Anti-HER2 monoclonal antibody; EGFR tyrosine kinase inhibitor; ErbB family blocker; Locally advanced breast cancer; Phase II;
Discovery of a novel class anti-proliferative agents and potential inhibitors of EGFR tyrosine kinases based on 4-anilinotetrahydropyrido[4,3-d]pyrimidine scaffold: Design, synthesis and biological evaluations
Keywords: بازدارنده تیروزیین کیناز EGFR; Tetrahydropyrido[4,3-d]pyrimidine (THPP); Anti-proliferative agents; EGFR tyrosine kinase inhibitor;
Spheroid Culture of Primary Lung Cancer Cells with Neuregulin 1/HER3 Pathway Activation
Keywords: بازدارنده تیروزیین کیناز EGFR; Primary culture; Non–small-cell lung cancer; EGFR tyrosine kinase inhibitor; Neuregulin 1; HER3
Use of erlotinib throughout pregnancy: A case-report of a patient with metastatic lung adenocarcinoma
Keywords: بازدارنده تیروزیین کیناز EGFR; Lung cancer; Treatment; Metastasis; Non-small cell lung carcinoma; Lung adenocarcinoma; Erlotinib; Pregnancy; EGFR tyrosine kinase inhibitor
Miliary Never-Smoking Adenocarcinoma of the Lung: Strong Association with Epidermal Growth Factor Receptor Exon 19 Deletion
Keywords: بازدارنده تیروزیین کیناز EGFR; Adenocarcinoma of the lung; EGFR exon 19 deletion; EGFR tyrosine kinase inhibitor; Miliary lung metastases; Never smoker
Enhancement of EGFR tyrosine kinase inhibition by C–C multiple bonds-containing anilinoquinazolines
Keywords: بازدارنده تیروزیین کیناز EGFR; EGFR tyrosine kinase inhibitor; Anticancer agent; Quinazoline; C–C multiple bonds; Allene
EGFR T790M Mutation: A Double Role in Lung Cancer Cell Survival?
Keywords: بازدارنده تیروزیین کیناز EGFR; Molecular target therapy; EGFR mutation; Acquired resistance; EGFR tyrosine kinase inhibitor
Inhibiting the function of ABCB1 and ABCG2 by the EGFR tyrosine kinase inhibitor AG1478
Keywords: بازدارنده تیروزیین کیناز EGFR; EGFR tyrosine kinase inhibitor; Multidrug resistance; ABCB1; ABCG2
Design, synthesis and in vitro antitumor activity of 4-aminoquinoline and 4-aminoquinazoline derivatives targeting EGFR tyrosine kinase
Keywords: بازدارنده تیروزیین کیناز EGFR; Aminoquinazoline; Aminoquinoline; EGFR tyrosine kinase inhibitor; Antitumor activity; Docking study
Gefitinib ('Iressa'): a new therapy for advanced non-small-cell lung cancer
Keywords: بازدارنده تیروزیین کیناز EGFR; Non-small-cell lung cancer (NSCLC); Epidermal growth factor receptor (EGFR); EGFR tyrosine kinase inhibitor; Gefitinib; 'Iressa';